Clinical trial
Study of Methylnaltrexone (MNTX) for the Relief of Constipation
NCT00402038 · Bausch Health Americas, Inc., Industry · Completed
Key facts
| NCT number | NCT00402038 |
|---|---|
| Title | Study of Methylnaltrexone (MNTX) for the Relief of Constipation |
| Official title | A Double-Blind, Phase 3, Two-Week, Placebo Controlled Study of Methylnaltrexone(MNTX) for the Relief of Constipation Due to Opioid Therapy in Advance Medical Illness. |
| Lead sponsor | Bausch Health Americas, Inc., Industry |
| Collaborators | Wyeth is now a wholly owned subsidiary of Pfizer Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Advance Illness Patients With OIC |
| Intervention type | Drug |
| Interventions | SC Methylnaltrexone, SC Placebo |
| Enrollment | 134 |
| Start date | Feb 1, 2004 |
| Primary completion | Oct 1, 2005 |
| Completion | Oct 1, 2005 |
| First posted | Nov 22, 2006 |
| Last update posted | Nov 25, 2019 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: